Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 192

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

The three stages of epilepsy in patients with CDKL5 mutations

Bahi‐Buisson, Nadia, Kaminska, Anna, Boddaert, Nathalie, Rio, Marlène, Afenjar, Alexandra, Gérard, Marion, Giuliano, Fabienne, Motte, Jacques, Héron, Delphine, Morel, Marie Ange N'Guyen, Plouin, Perrine, Richelme, Christian, Des Portes, Vincent, Dulac, Olivier, Philippe, Christophe, Chiron, Catherine, Nabbout, Rima, Bienvenu, Thierry·2008·Epilepsia

Abstract

Summary: Mutations in the X‐linked cyclin‐dependent kinase‐like 5 (CDKL5) gene are responsible for a severe encephalopathy with early epilepsy. So far, the electroclinical phenotype remains largely unknown and no clear genotype–phenotype correlations have been established. Purpose: To characterize the epilepsy associated with CDKL5 mutations and to look for a relationship between the genotype and the course of epilepsy. Methods: We retrospectively analyzed the electroclinical phenotypes of 12 patients aged from 2.5 to 19 years diagnosed with pathogenic CDKL5 mutations and one patient with a novel intronic sequence variation of uncertain pathogenicity and examined whether the severity of the epilepsy was linked to the type and location of mutations. Results: The epilepsy course reveals three successive stages: (Stage I) early epilepsy (onset 1–10 weeks) with normal interictal electroencephalogram (EEG) (10/13) despite frequent convulsive seizures; (Stage II) epileptic encephalopathy with infantile spasms (8/8) and hypsarrhythmia (8/8). At the age of evaluation, seven patients were seizure free and six had developed refractory epilepsy (stage III) with tonic seizures and myoclonia (5/6). Interestingly, the patients carrying a CDKL5 mutations causing a truncation of the catalytic domain tended to develop a more frequent refractory epilepsy than patients with mutations located downstream (4/6, 66.6% versus 1/6, 16%) although, these trends are not yet significant. Discussion: Our data contribute to a better definition of the epileptic phenotype in CDKL5 mutations, and might give some clues to a potential relationship between the phenotype and the genotype in these patients.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1528-1167.2007.01520.x

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 192

Metadata

Authors
Bahi‐Buisson, N., Kaminska, A., Boddaert, N., Rio, M., Afenjar, A., Gérard, M., Giuliano, F., Motte, J., Héron, D., Morel, M. A. N., Plouin, P., Richelme, C., Des Portes, V., Dulac, O., Philippe, C., Chiron, C., Nabbout, R., & Bienvenu, T.
Venue
Epilepsia
Publisher
Wiley
Published
2008-02-07
Volume
49
Issue
6
Pages
1027-1037
ISSN
  • 0013-9580 (ISSN-L)
  • 1528-1167
OpenAlex
W2034720571
Cited by
192
References
1
FWCI
9.19
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The three stages of epilepsy in patients with CDKL5 mutations. https://app.cochat.ai/papers/10.1111/j.1528-1167.2007.01520.x
The paper
Bahi‐Buisson, N., Kaminska, A., Boddaert, N., Rio, M., Afenjar, A., Gérard, M., Giuliano, F., Motte, J., Héron, D., Morel, M. A. N., Plouin, P., Richelme, C., Des Portes, V., Dulac, O., Philippe, C., Chiron, C., Nabbout, R., & Bienvenu, T. (2008). The three stages of epilepsy in patients with CDKL5 mutations. Epilepsia. https://doi.org/10.1111/j.1528-1167.2007.01520.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.